Bausch Health Cos., Inc.
(Toronto Stock Exchange : VRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc 5.63%58.356.5%$171.43m
CTLTCatalent, Inc. 0.54%73.132.1%$127.43m
JAZZJazz Pharmaceuticals Plc 1.91%111.852.4%$113.61m
VRXValeant Pharmaceuticals International, Inc. 4.14%19.1014.1%$112.39m
BHCBausch Health Cos., Inc. 4.09%19.090.0%$84.17m
UTHRUnited Therapeutics Corp. -0.74%119.4414.3%$72.56m
ICPTIntercept Pharmaceuticals, Inc. 1.19%47.6516.8%$61.80m
AXSMAxsome Therapeutics, Inc. 2.04%82.621.9%$53.80m
ZGNXZogenix, Inc. 1.75%29.707.5%$51.60m
PRGOPerrigo Co. Plc 0.31%55.366.8%$49.25m
MYOKMyoKardia, Inc. -1.35%92.841.8%$46.31m
AMRNAmarin Corp. Plc 1.03%6.991.6%$43.94m
PCRXPacira Biosciences, Inc. 5.00%54.9910.3%$42.00m
ARGXargenx SE 3.15%235.920.0%$41.45m
ICLRICON plc 1.61%169.594.3%$39.18m

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.